SAN JOSE, CA – Feb 25th, 2025 – Codex Labs (https://www.codexlabscorp.com/), a Silicon Valley skintech company, has launched the first of its Bia over-the-counter (OTC) topicals for eczema management. Bia, meaning “food” in Gaelic, is often paired with “nourishment” in Celtic philosophy.
The BIA eczema lotion leverages the patent-pending BiaComplex 2.0™, a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses hydration, skin barrier repair (both increased ceramide and structural protein production), and itch reduction in distinct yet synergistically-effective ways.
“At Codex Labs, we are excited to expand the clinical effectiveness of our plant-biotech-based skincare solutions to addressing itch and dryness symptoms associated with atopic dermatitis, or eczema,” stated Dr. Barbara Paldus, CEO and Founder of Codex Labs. “By doing so, we have further demonstrated our commitment to bringing much-needed relief to people suffering from inflammation-based skin conditions.”
The OTC Eczema Relief Lotion was designed to be used in conjunction with the Bia Unscented Soap, the first vegan, MyMicrobiome-certified soap launched in 2021. The combination, called “Eczema Essentials,” delivers skin hydration, moisture retention, skin barrier repair, and relief from itching.
“The Eczema Essentials set was tested in a clinical study and performed well for managing mild to moderate eczema. It is remarkable to think that these are over-the-counter products, available to everyone without a prescription,” stated Dr. Peter Lio, a leading US expert in pediatric eczema and Codex Labs Medical Advisory Board member.
The Eczema Essentials set was also combined with the Antu Skin Barrier Support supplement in a trio called “Ditch the Itch.” The addition of the Antu supplement provides l-histidine, an amino acid used by the body for filaggrin protein and natural moisturizing factor production, as well as a novel antioxidant from Patagonia (M3™) that helps address internal inflammation by combatting free radicals production and lipid peroxidation.
This topical-ingestible “Ditch the Itch” trio underwent a clinical trial on subjects having mild to moderate eczema (SCORAD = 34.5). The measured improvement in 8 weeks included:
-
93% reduction in eczema score (SCORAD) in 100% of subjects
-
88% reduction of itch in 97% of subjects
-
117% hydration increase in 91% of subjects
-
83% flakiness (desquamation) decrease in 97% of subjects
-
29% trans-epidermal water loss (TEWL) reduction in 79% of subjects
The clinical results of this combined inside-out approach demonstrate the importance of addressing skin conditions with both topicals and ingestibles in an integrative skin-gut approach.
All three products are vegan- and cruelty-free, and the two topicals are also MyMicrobiome-certified. All Codex products are manufactured in high-tech GMP (Good Manufacturing Practice) facilities to ensure they are made to the highest quality standards. They contain sustainably optimized ingredients and are filled in renewable, sugarcane green PE tubes, which reduces their carbon footprint by over 50%.
About Codex Labs
Based in Silicon Valley and led by scientist Dr. Barb Paldus, Codex Labs is committed to creating highly effective, clinically proven, microbiome-supporting skin-gut-brain-biome solutions that contain potent, biotech-derived plant-based actives. Our products are focused on restoring/protecting the skin barrier, managing inflammation, and addressing skin conditions associated with aging, acne, eczema, and psoriasis. The brand has been heralded by integrative dermatologists and naturopathic doctors for creating the next generation of effective, vegan, cruelty-free, and sustainable dermaceutical solutions.
Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email: Send Email
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: www.otterpr.com